These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8851473)

  • 1. Analogues of carbacholine: synthesis and relationship between structure and affinity for muscarinic and nicotinic acetylcholine receptors.
    Søkilde B; Mikkelsen I; Stensbøl TB; Andersen B; Ebdrup S; Krogsgaard-Larsen P; Falch E
    Arch Pharm (Weinheim); 1996 Feb; 329(2):95-104. PubMed ID: 8851473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors.
    Abood LG; Saraswati M; Lerner-Marmarosh N; Hashmi M
    Biochem Pharmacol; 1993 May; 45(10):2143-8. PubMed ID: 8512596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
    Pei XF; Gupta TH; Badio B; Padgett WL; Daly JW
    J Med Chem; 1998 Jun; 41(12):2047-55. PubMed ID: 9622546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annulated heterocyclic bioisosteres of norarecoline. Synthesis and molecular pharmacology at five recombinant human muscarinic acetylcholine receptors.
    Bräuner-Osborne H; Ebert B; Brann MR; Falch E; Krogsgaard-Larsen P
    J Med Chem; 1995 Jun; 38(12):2188-95. PubMed ID: 7783150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibition of [3H]-oxotremorine-M and [3H]-quinuclinidyl benzilate binding to muscarinic receptors in rat brain membranes with acetylcholinesterase inhibitors.
    Lockhart B; Closier M; Howard K; Steward C; Lestage P
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):429-38. PubMed ID: 11330337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.
    Daly JW; Gupta TH; Padgett WL; Pei XF
    J Med Chem; 2000 Jun; 43(13):2514-22. PubMed ID: 10891110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.
    Sharif NA; Williams GW; DeSantis LM
    Neurochem Res; 1995 Jun; 20(6):669-74. PubMed ID: 7566362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation by nicotine on binding of cerebral muscarinic receptors with muscarinic agonist and antagonist.
    Wang H; Cui WY; Liu CH
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):497-9. PubMed ID: 9863140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Bromoacetamidoprocaine: an affinity ligand for brain muscarinic and nicotinic cholinergic receptors.
    Saraswati M; Hashmi M; Abood LG
    Neurochem Res; 1992 Mar; 17(3):247-52. PubMed ID: 1620268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in ligand binding and phosphoinositide turnover between M1 muscarinic receptor gene transfected cells and mouse and rat brain membranes.
    Wang DX; Lerner-Marmarosh N; Sheu SS; Sharma V; Jou MJ; Abood LG
    Pharmacol Biochem Behav; 1994 Oct; 49(2):405-11. PubMed ID: 7824557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional differences in the binding of selective muscarinic receptor antagonists in rat brain: comparison with minimum-energy conformations.
    Messer WS; Ellerbrock BR; Smith DA; Hoss W
    J Med Chem; 1989 Jun; 32(6):1164-72. PubMed ID: 2724292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain.
    Anderson DJ; Arneric SP
    Eur J Pharmacol; 1994 Mar; 253(3):261-7. PubMed ID: 8200419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors.
    Jensen AA; Mikkelsen I; Frølund B; Bräuner-Osborne H; Falch E; Krogsgaard-Larsen P
    Mol Pharmacol; 2003 Oct; 64(4):865-75. PubMed ID: 14500743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological activity of N-methyl-carbamylcholine, a novel acetylcholine receptor agonist with selectivity for nicotinic receptors.
    Boksa P; Quik M; Mitchell JB; Collier B; O'Neil W; Quirion R
    Eur J Pharmacol; 1989 Nov; 173(1):93-108. PubMed ID: 2606158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines .
    Sauerberg P; Olesen PH; Nielsen S; Treppendahl S; Sheardown MJ; Honoré T; Mitch CH; Ward JS; Pike AJ; Bymaster FP
    J Med Chem; 1992 Jun; 35(12):2274-83. PubMed ID: 1613751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]N-methyl-carbamylcholine, a new radioligand specific for nicotinic acetylcholine receptors in brain.
    Boksa P; Quirion R
    Eur J Pharmacol; 1987 Jul; 139(3):323-33. PubMed ID: 3666008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
    Lee W; Wolfe BB
    Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.